Health Canada has asked Canadian importers to quarantine drug products manufactured at two facilities in India as a precautionary measure.
Indian pharmaceutical research company Aurobindo Pharma is facing legal action from three large international competitors that have accused the company of patent infringement.
The FDA’s campaign against substandard pharmaceutical products manufactured in India is continuing with a new import ban, this time imposed on drugs produced at a Bangalore facility owned and operated by Canadian company Apotex Inc.
The U.S. pharmaceutical supply chain is predicted to go through a stage of consolidation which will have an impact on the Indian drug manufacturing market, according to industry experts.
Mumbai-based pharmaceutical firm Wockhardt Ltd has announced that it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the import alert on production originating from the company’s Waluj facility in India.